Rebalance’s Northrop Grumman NOC Stock Holding History

Rebalance’s Portfolio NOC Stock Details NOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-101	Closed	-$54.8K	–	113
2022 Q4	$54.8K	Buy	+101	New	+$52.7K	0.01%	99

Other funds holding NOC

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rebalance's NOC Position: Q1 2023 in Review

Rebalance sold out of Northrop Grumman (NOC) in Q1 2023, closing a stake of 101 shares — an estimated $54.8K sold.

Rebalance first reported a position in NOC in Q4 2022 and held it in 1 quarter. The position peaked at $54.8K in Q4 2022. 1,414 funds tracked by Wall St. Rank hold NOC as of Q1 2023.

Rebalance reported no remaining Northrop Grumman position as of Q1 2023 after selling out during the quarter.
Rebalance sold 101 Northrop Grumman shares in Q1 2023, an estimated $54.8K.
Rebalance first reported a position in Northrop Grumman in Q4 2022 and held it in 1 quarter.
Rebalance's Northrop Grumman position peaked at $54.8K in Q4 2022.
1,414 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2023.

Based on Rebalance's 13F filing for Q1 2023, filed 3 May 2023.